Clinical Trials Logo

Antibiotic-associated Diarrhea clinical trials

View clinical trials related to Antibiotic-associated Diarrhea.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04277156 Not yet recruiting - Clinical trials for Antibiotic-associated Diarrhea

L Rhamnosus ATCC 53103 & L Reuteri DSM 29063 Compared With L Rhamnosus ATCC 53103 for Preventing AAD in Children

FLOSTRUM
Start date: February 2020
Phase: N/A
Study type: Interventional

This study will use a noninferiority design to examine whether the administration of L rhamnosus ATCC 53103 & L reuteri DSM 29063 (Flostrum Baby) is no worse than (or as good as) the administration of a recommended probiotic L rhamnosus ATCC 53103 (commercially available as Dicoflor, hereafter a reference product) for the prevention of antibiotic-associated diarrhea in children,

NCT ID: NCT02993419 Not yet recruiting - Clinical trials for Antibiotic-associated Diarrhea

Bacillus Particles Prevent Children Antibiotics Associated Diarrhea

Start date: December 2016
Phase: Phase 4
Study type: Interventional

This prospective, multicenter, randomized, double-blind, placebo-controlled clinical study, into the group of children in the hospital that use clinical antibiotics from one month to three years old,by observing the given antibiotics at the same time with the whole bowel raw or placebo, prevent the happening of the antibiotic associated diarrhea, evaluate the whole bowel prevention clinical efficacy and safety of AAD.

NCT ID: NCT02856386 Not yet recruiting - Clinical trials for Antibiotic-associated Diarrhea

Use of a Dietary Supplement to Support Digestive Health in Children With Chronic Diarrhea

Start date: August 2016
Phase: N/A
Study type: Interventional

Micronutrients missing in the diet may assist in supporting digestive health in children with chronic GI issues. This study will monitor changes in symptoms associated with digestive problems in children provided with a dietary supplement that will be taken in conjunction with the standard of care.

NCT ID: NCT00792844 Not yet recruiting - Clinical trials for Antibiotic-Associated Diarrhea

Comparison of Two Formulations of Bio-K

Start date: February 2009
Phase: N/A
Study type: Interventional

Main research Question: The investigators would like to find out if both the Bio-K (lactobacillus acidophilus and lactobacillus casei) drink and capsule are equally effective in the prevention of diarrhea associated with antibiotic use. Why is this research project important? About 25% of patients who use antibiotics may develop diarrhea as a side effect. Symptoms are mild and consist of watery diarrhea and abdominal pain. Some patients may develop a more severe form of diarrhea, called clostridium difficile-associated diarrhea. Clostridium difficile-associated diarrhea may lead to more serious consequences like inflammation of the large bowel and in some cases, death. There are some studies that suggest Bio-K drink, a probiotic preparation containing lactobacillus acidophilus and lactobacillus casei, decreases the risk of diarrhea from antibiotic use. As a result, St. Joseph's Healthcare has recently to use Bio-K routinely to try to reduce risk of patients developing diarrhea. No other Hamilton hospitals use Bio-K routinely as there is not strong evidence about the effectiveness of Bio-K for the prevention of diarrhea. This study will provide more information about Bio-K's effectiveness in the prevention of diarrhea associated with antibiotic use as both a capsule and a drink.

NCT ID: NCT00658151 Not yet recruiting - Clinical trials for Antibiotic-Associated Diarrhea

Ultrasound Diagnosis of Antibiotic Associated Diarrhea

Start date: April 2008
Phase: N/A
Study type: Observational

The hypothesis is that there are unique sonographic characteristics of antibiotic-associated diarrhea. We will compare the ultrasound findings in patients who received antibiotics and developed diarrhea to toxin analysis for clostridium difficile in stool in order to find differences in the sonographic findings in the positive and negative cases.